Cargando…

A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides

From a human histocompatibility leukocyte antigen (HLA)-DR/DQ hemizygous, B lymphoblastoid progenitor, we isolated a cell line, 10.24.6, with a DR alpha missense mutation (96P-->96S), which results in an N-linked carbohydrate addition at position 94 in the DR alpha 2 domain. Several features of 1...

Descripción completa

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1994
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191365/ https://www.ncbi.nlm.nih.gov/pubmed/8294865

Ejemplares similares

T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules
Publicado: (1992)

A single amino acid substitution in the human histocompatibility leukocyte antigen DR3 beta chain selectively alters antigen presentation
Publicado: (1988)

Distinct Intracellular Compartments Involved in Invariant Chain Degradation and Antigenic Peptide Loading of Major Histocompatibility Complex (MHC) Class II Molecules
por: Ferrari, Giorgio, et al.
Publicado: (1997)

Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs
Publicado: (1996)

Modulation of the Major Histocompatibility Complex Class II–Associated Peptide Repertoire by Human Histocompatibility Leukocyte Antigen (Hla)-Do
por: van Ham, Marieke, et al.
Publicado: (2000)

Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules
Publicado: (1996)

Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain
Publicado: (1991)

Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules
Publicado: (1995)

In Vivo Evidence for the Contribution of Human Histocompatibility Leukocyte Antigen (Hla)-Dq Molecules to the Development of Diabetes
por: Wen, Li, et al.
Publicado: (2000)

Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain
Publicado: (1986)

Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles
Publicado: (1995)

The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules
Publicado: (1994)

Boosting immune response with the invariant chain segments via association with non-peptide binding region of major histocompatibility complex class II molecules
por: Chen, Fangfang, et al.
Publicado: (2012)

Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain
Publicado: (1990)

Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice
Publicado: (1994)

Human Histocompatibility Leukocyte Antigen (HLA)-G Molecules Inhibit NKAT3 Expressing Natural Killer Cells
por: Münz, Christian, et al.
Publicado: (1997)

Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class 1 molecule on cytotrophoblasts
Publicado: (1991)

Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA- B35 subtype molecules
Publicado: (1995)

Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines
Publicado: (1994)

Novel Mutants Define Genes Required for the Expression of Human Histocompatibility Leukocyte Antigen DM: Evidence for Loci on Human Chromosome 6p
por: Fling, Steven P., et al.
Publicado: (1997)

Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH
Publicado: (1994)

Role for Cathepsin F in Invariant Chain Processing and Major Histocompatibility Complex Class II Peptide Loading by Macrophages
por: Shi, Guo-Ping, et al.
Publicado: (2000)

Cytotoxicity of Histocompatibility Leukocyte Antigen–DR8–restricted CD4(+) Killer T Cells against Human Autologous Squamous Cell Carcinoma
por: Miyazaki, Akihiro, et al.
Publicado: (1997)

Extracellular processing of peptide antigens that bind class I major histocompatibility molecules
Publicado: (1992)

Melanoma Cells Present a MAGE-3 Epitope to CD4(+) Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11
por: Manici, Simona, et al.
Publicado: (1999)

Structural Features of Peptide Analogs of Human Histocompatibility Leukocyte Antigen Class I Epitopes That Are More Potent and Immunogenic than Wild-Type Peptide
por: Tangri, Shabnam, et al.
Publicado: (2001)

Suppression of class I human histocompatibility leukocyte antigen by c- myc is locus specific
Publicado: (1989)

Analysis of Naturally Processed Human Histocompatibility Leukocyte Antigen Class I‐Bound Peptides from Hepatocellular Carcinoma Tissues in vivo
por: Kobayashi, Hiroya, et al.
Publicado: (1995)

Efficient endosomal localization of major histocompatibility complex class II-invariant chain complexes requires multimerization of the invariant chain targeting sequence
Publicado: (1995)

Identification of parathyroid hormone-related protein-derived peptides immunogenic in human histocompatibility leukocyte antigen-A24(+) prostate cancer patients
por: Yao, A, et al.
Publicado: (2004)

Coordinate defects in human histocompatibility leukocyte antigen class II expression and antigen presentation in bare lymphocyte syndrome
Publicado: (1994)

Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II
Publicado: (1995)

PHENOTYPIC EXPRESSIONS OF THE MAJOR HISTOCOMPATIBILITY LOCUS IN MAN (HL-A): LEUKOCYTE ANTIGENS AND MIXED LEUKOCYTE CULTURE REACTIVITY
por: Amos, D. Bernard, et al.
Publicado: (1968)

Association between human leukocyte antigen-DR and demylinating Guillain-Barré syndrome
por: Hasan, Zaki N., et al.
Publicado: (2014)

The Specificity of Peptides Bound to Human Histocompatibility Leukocyte Antigen (HLA)-B27 Influences the Prevalence of Arthritis in HLA-B27 Transgenic Rats
por: Zhou, Ming, et al.
Publicado: (1998)

Invariant Chain–independent Function of H-2M in the Formation of Endogenous Peptide–Major Histocompatibility Complex Class II Complexes In Vivo
por: Kovats, Susan, et al.
Publicado: (1998)

Regulated Expression of Human Histocompatibility Leukocyte Antigen (HLA)-DO During Antigen-dependent and Antigen-independent Phases of B Cell Development
por: Chen, Xinjian, et al.
Publicado: (2002)

Tetrameric Complexes of Human Histocompatibility Leukocyte Antigen (HLA)-G Bind to Peripheral Blood Myelomonocytic Cells
por: Allan, David S.J., et al.
Publicado: (1999)

Degradation of Mouse Invariant Chain: Roles of Cathepsins S and D and the Influence of Major Histocompatibility Complex Polymorphism
por: Villadangos, José A., et al.
Publicado: (1997)

T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_29p8lg8jeun3pgiu1ujso3h4bs